Lipid-Lowering Therapy and Hemorrhagic Stroke: A Never-Ending Debate of Clinical Implications. Have We Found the Answer?

David Gaist, Magdy Selim

Journal: Journal of the American Heart Association 2024;13(4):e034099

PMID: 38323520

Abstract

Address: Research Unit for Neurology Odense University Hospital, University of Southern Denmark Odense Denmark.; Department of Neurology, Stroke Division Beth Israel Deaconess Medical Center/Harvard Medical School Boston MA USA.

DOI: 10.1161/JAHA.124.034099

Link outs

Free resources

Full Text Sources:

https://www.ahajournals.org/doi/10.1161/JAHA.124.0...
https://pmc.ncbi.nlm.nih.gov/articles/pmid/3832352...
https://europepmc.org/abstract/MED/38323520

Medical:

https://medlineplus.gov/cholesterolmedicines.html

MeSH Terms: Humans, Hemorrhagic Stroke, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke, Lipids